首页 > 最新文献

Urology最新文献

英文 中文
Urologist's fatigue and discomfort in different body regions after performing flexible ureteroscopy.
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.04.004
Sarah Razavi, Emeka Udedibia, Kristin L Chrouser, Hamid Norasi, M Susan Hallbeck, Arun Rai, Stephanie Izard, Karen Huang, David Hoenig, Zeph Okeke

Objective: To assess self -reported surgeon fatigue and discomfort in different body regions after performing flexible ureteroscopy.

Methods: An anonymous survey was designed and distributed among urologists and trainees in four hospitals. Participants rated their discomfort in different body and hand regions as well as overall fatigue before and immediately after each flexible ureteroscopy procedure they performed.

Results: The final working sample size was 45 unique surgeons (26 female and 19 male) completing 58 procedures. Respondents were 38.2 ±14.7 years of age. Forty-two percent of respondents were male, 75% were right-hand dominant and 25% reported existing musculoskeletal disorder. Urologists' overall fatigue score significantly increased after ureteroscopy, but females had a significantly larger increase (female β: 1.74, p<0.001; male β: 0.78, p=0.017). Women experienced higher discomfort in neck, upper back, right shoulder and right elbow than men. Across different hand regions, increased post-procedural discomfort was reported mostly in the thenar area (41.8 %) followed by hypothenar area (28.5%) and thumb area (27.9%).

Discussion: Urologists experience significant increase in overall fatigue and discomfort across most body and hand regions. Women seem to be disproportionally affected. Additional studies are needed to determine the causality of these findings and explore potential interventions aimed at reducing procedure-related discomfort among all urologists, especially women.

{"title":"Urologist's fatigue and discomfort in different body regions after performing flexible ureteroscopy.","authors":"Sarah Razavi, Emeka Udedibia, Kristin L Chrouser, Hamid Norasi, M Susan Hallbeck, Arun Rai, Stephanie Izard, Karen Huang, David Hoenig, Zeph Okeke","doi":"10.1016/j.urology.2025.04.004","DOIUrl":"https://doi.org/10.1016/j.urology.2025.04.004","url":null,"abstract":"<p><strong>Objective: </strong>To assess self -reported surgeon fatigue and discomfort in different body regions after performing flexible ureteroscopy.</p><p><strong>Methods: </strong>An anonymous survey was designed and distributed among urologists and trainees in four hospitals. Participants rated their discomfort in different body and hand regions as well as overall fatigue before and immediately after each flexible ureteroscopy procedure they performed.</p><p><strong>Results: </strong>The final working sample size was 45 unique surgeons (26 female and 19 male) completing 58 procedures. Respondents were 38.2 ±14.7 years of age. Forty-two percent of respondents were male, 75% were right-hand dominant and 25% reported existing musculoskeletal disorder. Urologists' overall fatigue score significantly increased after ureteroscopy, but females had a significantly larger increase (female β: 1.74, p<0.001; male β: 0.78, p=0.017). Women experienced higher discomfort in neck, upper back, right shoulder and right elbow than men. Across different hand regions, increased post-procedural discomfort was reported mostly in the thenar area (41.8 %) followed by hypothenar area (28.5%) and thumb area (27.9%).</p><p><strong>Discussion: </strong>Urologists experience significant increase in overall fatigue and discomfort across most body and hand regions. Women seem to be disproportionally affected. Additional studies are needed to determine the causality of these findings and explore potential interventions aimed at reducing procedure-related discomfort among all urologists, especially women.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Private Equity in Healthcare.
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.03.049
Wesley M White, Abhilash Moolupuri, Ray Pak

Healthcare in the United States is in a time of great transition. Consolidation and corporatization are increasingly normalized. Physician autonomy and self-determination has been deprioritized, contributing to burnout and workforce shortages. One of the most striking and controversial evolutions has been the entry of Private Equity investment into medicine. In this review article, we will explain the construct of Private Equity, its rationale for investing in medical practices including urology, and the potential benefits and risks of physician partnership.

{"title":"Private Equity in Healthcare.","authors":"Wesley M White, Abhilash Moolupuri, Ray Pak","doi":"10.1016/j.urology.2025.03.049","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.049","url":null,"abstract":"<p><p>Healthcare in the United States is in a time of great transition. Consolidation and corporatization are increasingly normalized. Physician autonomy and self-determination has been deprioritized, contributing to burnout and workforce shortages. One of the most striking and controversial evolutions has been the entry of Private Equity investment into medicine. In this review article, we will explain the construct of Private Equity, its rationale for investing in medical practices including urology, and the potential benefits and risks of physician partnership.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial comments on Survival outcomes and temporal trends of non-surgical management versus radical cystectomy in non-organ-confined urothelial bladder cancer.
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.04.006
Kazutaka Saito, Akinari Nakayama
{"title":"Editorial comments on Survival outcomes and temporal trends of non-surgical management versus radical cystectomy in non-organ-confined urothelial bladder cancer.","authors":"Kazutaka Saito, Akinari Nakayama","doi":"10.1016/j.urology.2025.04.006","DOIUrl":"https://doi.org/10.1016/j.urology.2025.04.006","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing Public Interest in Online Men's Health Services: A Cross-Sectional Google Trends Analysis of "Hims". 评估公众对在线男性健康服务的兴趣:对 "Hims "的谷歌趋势跨部门分析。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.03.041
Jack Considine, Shane Tinsley, Amarnath Rambhatla, Ali Dabaja, Logan Hubbard

Objective: To evaluate public interest in "Hims," a men's health platform, to assess its impact on healthcare access, and identify geographic trends reflecting gaps in traditional healthcare availability.

Methods: Relative search volume data for erectile dysfunction and early climax terms in "Hims" were collected via Google Trends from November 2017 to December 2023 across the United States. Data were analyzed in two intervals (2017-2020 and 2020-2023) using paired t-tests to compare relative search volume and Kruskal-Wallis tests to assess differences among terms. Geographic regions were examined to identify underserved regions.

Results: Public interest in "Hims" increased significantly, with median relative search volume rising from 0 (interquartile range: 0-33) in 2017-2020 to 62 (interquartile range: 30-95) in 2020-2023 (p < 0.05). Searches related to erectile dysfunction rose from a median relative search volume of 18 (interquartile range: 0-100) to 46 (interquartile range: 0-100) (p < 0.001), with similar growth observed in searches related to early climax. High relative search volume was noted in states like Colorado, Wyoming, and Maine, highlighting increased interest in regions with limited healthcare resources. A marked rise in telehealth engagement during the COVID-19 pandemic further emphasized the role of digital platforms in healthcare delivery during periods of restricted access.

Conclusions: The rise in search interest for "Hims" underscores the increasing demand for telehealth services to for men's health, particularly in underserved regions. These findings highlight the potential of digital platforms to bridge gaps in healthcare access.

{"title":"Assessing Public Interest in Online Men's Health Services: A Cross-Sectional Google Trends Analysis of \"Hims\".","authors":"Jack Considine, Shane Tinsley, Amarnath Rambhatla, Ali Dabaja, Logan Hubbard","doi":"10.1016/j.urology.2025.03.041","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.041","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate public interest in \"Hims,\" a men's health platform, to assess its impact on healthcare access, and identify geographic trends reflecting gaps in traditional healthcare availability.</p><p><strong>Methods: </strong>Relative search volume data for erectile dysfunction and early climax terms in \"Hims\" were collected via Google Trends from November 2017 to December 2023 across the United States. Data were analyzed in two intervals (2017-2020 and 2020-2023) using paired t-tests to compare relative search volume and Kruskal-Wallis tests to assess differences among terms. Geographic regions were examined to identify underserved regions.</p><p><strong>Results: </strong>Public interest in \"Hims\" increased significantly, with median relative search volume rising from 0 (interquartile range: 0-33) in 2017-2020 to 62 (interquartile range: 30-95) in 2020-2023 (p < 0.05). Searches related to erectile dysfunction rose from a median relative search volume of 18 (interquartile range: 0-100) to 46 (interquartile range: 0-100) (p < 0.001), with similar growth observed in searches related to early climax. High relative search volume was noted in states like Colorado, Wyoming, and Maine, highlighting increased interest in regions with limited healthcare resources. A marked rise in telehealth engagement during the COVID-19 pandemic further emphasized the role of digital platforms in healthcare delivery during periods of restricted access.</p><p><strong>Conclusions: </strong>The rise in search interest for \"Hims\" underscores the increasing demand for telehealth services to for men's health, particularly in underserved regions. These findings highlight the potential of digital platforms to bridge gaps in healthcare access.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Performance and Safety for the Rechargeable InterStim Micro System in Non-Obstructive Urinary Retention Subjects: 6-Month Results from the Global Post-Market ELITE study. 可充电 InterStim Micro 系统在非梗阻性尿潴留患者中的临床表现和安全性:全球上市后 ELITE 研究的 6 个月结果。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.03.057
Sachin Malde, Victoria Lavin, Marie-Aimée Perrouin-Verbe, Dean Elterman, Benoît Peyronnet, Martijn Smits, Sagar Shah, Keith Xavier, Ryan Krlin, Raviender Bukkapatnam, Bianca Papi, Mylène Champs, Colin Goudelocke, Arun Sahai

Objectives: To confirm the clinical performance and safety of the rechargeable InterStimTM Micro sacral neuromodulation system, we report the first results from the global ELITE study for the non-obstructive urinary retention (NOUR) cohort through 6 months of follow-up.

Methods: Subjects were enrolled following successful therapy evaluation and neurostimulator implant. The primary objective was improvement in the number of clean intermittent self-catheterizations (CISC) per day at 3-months post-implant compared to baseline.

Results: The change in number of CISC per day from baseline was -3.5 (95% CI: -4.77, -2.26; n=23) at 3-month follow-up, which was statistically significant (p<0.001) and signifies that the primary objective was met. This change was sustained at 6-month follow-up, with a change of -3.5 (95% CI: -4.73, -2.29; n=24). There was a reduction in post-void residual of 244 mL (95% CI: -334.6, -154; n=22) at 3 months and 264 mL (95% CI: -366.43, -161.56; n=21) at 6 months vs baseline. On the Patient Global Impression of Improvement, 88% and 79% of subjects reported that their bladder condition was better at 3 and 6 months, respectively, compared to before they were treated with InterStim Micro. Device-, procedure-, or therapy-related AEs included implant site pain (11.1%; 3/27), medical device site discomfort (7.4%; 2/27) and pain in extremity (7.4%; 2/27).

Conclusions: This study reports on the NOUR population of the global ELITE study, demonstrating efficacy and safety of the InterStim Micro system through 6 months of follow-up.

{"title":"Clinical Performance and Safety for the Rechargeable InterStim Micro System in Non-Obstructive Urinary Retention Subjects: 6-Month Results from the Global Post-Market ELITE study.","authors":"Sachin Malde, Victoria Lavin, Marie-Aimée Perrouin-Verbe, Dean Elterman, Benoît Peyronnet, Martijn Smits, Sagar Shah, Keith Xavier, Ryan Krlin, Raviender Bukkapatnam, Bianca Papi, Mylène Champs, Colin Goudelocke, Arun Sahai","doi":"10.1016/j.urology.2025.03.057","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.057","url":null,"abstract":"<p><strong>Objectives: </strong>To confirm the clinical performance and safety of the rechargeable InterStim<sup>TM</sup> Micro sacral neuromodulation system, we report the first results from the global ELITE study for the non-obstructive urinary retention (NOUR) cohort through 6 months of follow-up.</p><p><strong>Methods: </strong>Subjects were enrolled following successful therapy evaluation and neurostimulator implant. The primary objective was improvement in the number of clean intermittent self-catheterizations (CISC) per day at 3-months post-implant compared to baseline.</p><p><strong>Results: </strong>The change in number of CISC per day from baseline was -3.5 (95% CI: -4.77, -2.26; n=23) at 3-month follow-up, which was statistically significant (p<0.001) and signifies that the primary objective was met. This change was sustained at 6-month follow-up, with a change of -3.5 (95% CI: -4.73, -2.29; n=24). There was a reduction in post-void residual of 244 mL (95% CI: -334.6, -154; n=22) at 3 months and 264 mL (95% CI: -366.43, -161.56; n=21) at 6 months vs baseline. On the Patient Global Impression of Improvement, 88% and 79% of subjects reported that their bladder condition was better at 3 and 6 months, respectively, compared to before they were treated with InterStim Micro. Device-, procedure-, or therapy-related AEs included implant site pain (11.1%; 3/27), medical device site discomfort (7.4%; 2/27) and pain in extremity (7.4%; 2/27).</p><p><strong>Conclusions: </strong>This study reports on the NOUR population of the global ELITE study, demonstrating efficacy and safety of the InterStim Micro system through 6 months of follow-up.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applying a Process Improvement Approach to Optimize Operating Room Turnover in Urology. 应用流程改进方法优化泌尿外科手术室周转率。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.03.058
Emily Huang, Suyog Iswalkar, Sharlyn Leh, Rohit Nayak, Kathleen Kobashi

Objective: To apply a process improvement approach to optimizing operating room (OR) turnover time at an ambulatory surgery center.

Methods: Turnover was defined as the time a patient leaves the OR to the time the room is ready to receive the next patient. This process was observed multiple times to define the steps and operators involved. Each step was timed and meticulously studied to identify opportunities for improvement. New times for each step were obtained. The projected impact on the system capacity and potential financial implications were calculated using $1 per second as the "rent" of an OR.

Results: The OR turnover baseline time ranged from 31:45 to 42:49 minutes:seconds. Four opportunities for improvement were identified and proposed: 1) calling housekeeping earlier so they can be ready to enter the OR as the patient is being rolled out 2) mopping the floor starting from the side of the OR where the back table is located to allow back table preparation to proceed without delay 3) performing as much set up in the attached annex room as possible 4) rolling the next patient in as the scrub technician is scrubbing in and completing last minute organization. The theoretical financial benefits resulting from the implementation of these process improvements were calculated to be $1,559 per turnover, with an annual saving of $2,025,000 per individual OR.

Conclusion: By applying process improvement techniques, the authors uncovered a multitude of opportunities to improve the OR turnover process which, if optimized, could generate significant financial benefit.

目的采用流程改进方法优化门诊手术中心手术室(OR)的周转时间:方法:周转时间是指从病人离开手术室到手术室准备好接收下一位病人的时间。对这一过程进行了多次观察,以确定相关步骤和操作人员。对每个步骤进行计时并仔细研究,以确定改进的机会。每个步骤都获得了新的时间。以每秒 1 美元作为手术室的 "租金",计算了对系统容量的预期影响和潜在的财务影响:手术室周转基线时间从 31:45 到 42:49 分秒不等。确定并提出了四个改进机会:1)提早通知内务人员,以便他们在病人被推出手术室时做好进入手术室的准备 2)从手术室后台所在的一侧开始拖地,以便后台的准备工作能及时进行 3)尽可能多地在附属房间进行准备工作 4)在擦洗技师擦洗病人并完成最后一分钟的整理工作时,将下一位病人推出手术室。据计算,实施这些流程改进带来的理论经济效益为每个营业额 1,559 美元,每个手术室每年可节省 2,025,000 美元:通过应用流程改进技术,作者发现了许多改进手术室周转流程的机会,如果对其进行优化,可以产生巨大的经济效益。
{"title":"Applying a Process Improvement Approach to Optimize Operating Room Turnover in Urology.","authors":"Emily Huang, Suyog Iswalkar, Sharlyn Leh, Rohit Nayak, Kathleen Kobashi","doi":"10.1016/j.urology.2025.03.058","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.058","url":null,"abstract":"<p><strong>Objective: </strong>To apply a process improvement approach to optimizing operating room (OR) turnover time at an ambulatory surgery center.</p><p><strong>Methods: </strong>Turnover was defined as the time a patient leaves the OR to the time the room is ready to receive the next patient. This process was observed multiple times to define the steps and operators involved. Each step was timed and meticulously studied to identify opportunities for improvement. New times for each step were obtained. The projected impact on the system capacity and potential financial implications were calculated using $1 per second as the \"rent\" of an OR.</p><p><strong>Results: </strong>The OR turnover baseline time ranged from 31:45 to 42:49 minutes:seconds. Four opportunities for improvement were identified and proposed: 1) calling housekeeping earlier so they can be ready to enter the OR as the patient is being rolled out 2) mopping the floor starting from the side of the OR where the back table is located to allow back table preparation to proceed without delay 3) performing as much set up in the attached annex room as possible 4) rolling the next patient in as the scrub technician is scrubbing in and completing last minute organization. The theoretical financial benefits resulting from the implementation of these process improvements were calculated to be $1,559 per turnover, with an annual saving of $2,025,000 per individual OR.</p><p><strong>Conclusion: </strong>By applying process improvement techniques, the authors uncovered a multitude of opportunities to improve the OR turnover process which, if optimized, could generate significant financial benefit.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Editorial Comment on "Failure of Prenatal Ultrasonography to Identify Classic Bladder Exstrophy in a Heavily Screened Population".
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-04 DOI: 10.1016/j.urology.2025.04.008
Ann Dekalo, Matan Friedman, Jacob Ben-Chaim, Yuval Bar-Yosef
{"title":"Reply to Editorial Comment on \"Failure of Prenatal Ultrasonography to Identify Classic Bladder Exstrophy in a Heavily Screened Population\".","authors":"Ann Dekalo, Matan Friedman, Jacob Ben-Chaim, Yuval Bar-Yosef","doi":"10.1016/j.urology.2025.04.008","DOIUrl":"https://doi.org/10.1016/j.urology.2025.04.008","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urobiome and Inflammation: A Systematic Review on Microbial Imbalances and Diagnostic Tools for Urinary Disorders.
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-03 DOI: 10.1016/j.urology.2025.03.050
Sara Palumbo, Giuseppe Lucarelli, Francesco Lasorsa, Rocco Damiano, Riccardo Autorino, Achille Aveta, Gianluca Spena, Sisto Perdonà, Pierluigi Russo, Carlo Giulioni, Angelo Cafarelli, Marco Finati, Salvatore Siracusano, Savio Domenico Pandolfo

Objective: To synthesize current knowledge on urobiome alterations, innovative diagnostic advancements, and emerging therapeutic strategies targeting urobiome dysbiosis in inflammatory urinary tract disorders, including urinary tract infections (UTIs), non-gonococcal urethritis (NGU), and interstitial cystitis.

Methods: A systematic review was conducted by screening the most important scientific databases. The search included the keywords: (microbiome) OR (microbial) OR (bacteria) OR (bacterial profile) AND (urine) OR (urinary) AND (first-morning sample) OR (first void). Only original studies in English involving human specimens were considered.

Results: Of the 760 articles initially identified, a final sample of 20 original studies met the inclusion criteria. Disruptions in the urobiome composition were associated with increased colonization by pathogens such as Escherichia coli and Mycoplasma genitalium, resulting in inflammation and recurrent urinary conditions. Advanced diagnostic techniques, including metaproteomics, metagenomics, and point-of-care assays like NG-LFA, demonstrated enhanced capabilities for rapid pathogen detection and differentiation of inflammatory conditions. Therapeutic interventions targeting urobiome dysbiosis, particularly probiotics (Lactobacillus rhamnosus, L. reuteri, L. crispatus), showed promising efficacy in reducing recurrence and inflammation in clinical trials.

Conclusions: Urobiome dysbiosis plays a critical role in inflammatory urinary tract disorders. Innovative diagnostic methods and targeted therapeutic approaches, especially probiotics, offer substantial potential to improve patient outcomes. Further research is warranted to refine these strategies and validate their clinical applicability.

{"title":"Urobiome and Inflammation: A Systematic Review on Microbial Imbalances and Diagnostic Tools for Urinary Disorders.","authors":"Sara Palumbo, Giuseppe Lucarelli, Francesco Lasorsa, Rocco Damiano, Riccardo Autorino, Achille Aveta, Gianluca Spena, Sisto Perdonà, Pierluigi Russo, Carlo Giulioni, Angelo Cafarelli, Marco Finati, Salvatore Siracusano, Savio Domenico Pandolfo","doi":"10.1016/j.urology.2025.03.050","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.050","url":null,"abstract":"<p><strong>Objective: </strong>To synthesize current knowledge on urobiome alterations, innovative diagnostic advancements, and emerging therapeutic strategies targeting urobiome dysbiosis in inflammatory urinary tract disorders, including urinary tract infections (UTIs), non-gonococcal urethritis (NGU), and interstitial cystitis.</p><p><strong>Methods: </strong>A systematic review was conducted by screening the most important scientific databases. The search included the keywords: (microbiome) OR (microbial) OR (bacteria) OR (bacterial profile) AND (urine) OR (urinary) AND (first-morning sample) OR (first void). Only original studies in English involving human specimens were considered.</p><p><strong>Results: </strong>Of the 760 articles initially identified, a final sample of 20 original studies met the inclusion criteria. Disruptions in the urobiome composition were associated with increased colonization by pathogens such as Escherichia coli and Mycoplasma genitalium, resulting in inflammation and recurrent urinary conditions. Advanced diagnostic techniques, including metaproteomics, metagenomics, and point-of-care assays like NG-LFA, demonstrated enhanced capabilities for rapid pathogen detection and differentiation of inflammatory conditions. Therapeutic interventions targeting urobiome dysbiosis, particularly probiotics (Lactobacillus rhamnosus, L. reuteri, L. crispatus), showed promising efficacy in reducing recurrence and inflammation in clinical trials.</p><p><strong>Conclusions: </strong>Urobiome dysbiosis plays a critical role in inflammatory urinary tract disorders. Innovative diagnostic methods and targeted therapeutic approaches, especially probiotics, offer substantial potential to improve patient outcomes. Further research is warranted to refine these strategies and validate their clinical applicability.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143788873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimal Approach to Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia: Is Less More?
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-03 DOI: 10.1016/j.urology.2025.03.040
Vi Nguyen, Clara Cerrato, Mimi V Nguyen, Michelle C Leach, Jamie L Finegan, Kevin C Zorn, Dean Elterman, Naeem Bhojani, Bilal Chughtai, Seth K Bechis

Objective: To evaluate postoperative outcomes after a minimal approach of water vapor thermal therapy (WVTT; Rezum, Boston Scientific, Marlborough, MA, USA), defined as 1 treatment per prostate lobe, among men with benign prostatic hyperplasia (BPH).

Methods: We performed a multi-institutional retrospective review of patients who underwent WVTT from 2018 to 2022. Propensity score matching (PSM) was utilized to generate patient cohorts based on number of treatments per lobe (1 per lobe, including median lobe if present [minimal group], vs ≥2 per lobe [non-minimal group]) matched for age, body mass index, and preoperative prostate volume. Primary outcome was postoperative complications and storage phase symptoms beyond 30 days. We then conducted a non-PSM independent T-test to analyze differences in International Prostate Symptom Score (IPSS), uroflowmetry, and surgical retreatment rate postoperatively.

Results: 146 patients were included, with 73 in each arm. The non-minimal group had their median lobe treated more frequently (p=0.021) and experienced higher postoperative de-novo retention (p=0.009) and urinary tract infection (p=0.003) rates. On multivariate analysis, increasing number of treatments (hazard ration [HR] 1.3, p= 0.039) and median lobe treatment (HR 4.7, p=0.008) were significant risk factors for postoperative storage phase symptoms. Mean IPSS and uroflowmetry parameters were similar at 1, 3, 6 and 12 months postoperatively. Surgical retreatment rates were comparable at 2 years (3% vs 1%; p=0.444).

Conclusion: Minimal approach to WVTT is associated with decreased postoperative complications with comparable IPSS, maximum flow rate, and surgical retreatment rate. Further studies are needed to investigate longer term outcomes.

{"title":"Minimal Approach to Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia: Is Less More?","authors":"Vi Nguyen, Clara Cerrato, Mimi V Nguyen, Michelle C Leach, Jamie L Finegan, Kevin C Zorn, Dean Elterman, Naeem Bhojani, Bilal Chughtai, Seth K Bechis","doi":"10.1016/j.urology.2025.03.040","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.040","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate postoperative outcomes after a minimal approach of water vapor thermal therapy (WVTT; Rezum, Boston Scientific, Marlborough, MA, USA), defined as 1 treatment per prostate lobe, among men with benign prostatic hyperplasia (BPH).</p><p><strong>Methods: </strong>We performed a multi-institutional retrospective review of patients who underwent WVTT from 2018 to 2022. Propensity score matching (PSM) was utilized to generate patient cohorts based on number of treatments per lobe (1 per lobe, including median lobe if present [minimal group], vs ≥2 per lobe [non-minimal group]) matched for age, body mass index, and preoperative prostate volume. Primary outcome was postoperative complications and storage phase symptoms beyond 30 days. We then conducted a non-PSM independent T-test to analyze differences in International Prostate Symptom Score (IPSS), uroflowmetry, and surgical retreatment rate postoperatively.</p><p><strong>Results: </strong>146 patients were included, with 73 in each arm. The non-minimal group had their median lobe treated more frequently (p=0.021) and experienced higher postoperative de-novo retention (p=0.009) and urinary tract infection (p=0.003) rates. On multivariate analysis, increasing number of treatments (hazard ration [HR] 1.3, p= 0.039) and median lobe treatment (HR 4.7, p=0.008) were significant risk factors for postoperative storage phase symptoms. Mean IPSS and uroflowmetry parameters were similar at 1, 3, 6 and 12 months postoperatively. Surgical retreatment rates were comparable at 2 years (3% vs 1%; p=0.444).</p><p><strong>Conclusion: </strong>Minimal approach to WVTT is associated with decreased postoperative complications with comparable IPSS, maximum flow rate, and surgical retreatment rate. Further studies are needed to investigate longer term outcomes.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic mass in a pediatric patient: a rare case of extraosseous Ewing sarcoma.
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-04-03 DOI: 10.1016/j.urology.2025.03.038
Deepansh Dalela, Sarah Attia, Dinesh Rakheja, Shane Batie, Alexandra Carolan, Irina Stanasel

Ewing sarcoma (ES) is a common malignant bone tumor in children, but primary extraosseous Ewing sarcoma (EES) in the pelvic region is particularly rare. We report a 21-month-old male with a 10-cm complex cystic mass adherent to the bladder. Core biopsy demonstrated a small round cell neoplasm positive for CD99, NKX2-2, and EWSR1:ERG fusion. The patient had a residual mass following induction chemotherapy, and underwent surgical resection with anterior detrusorrhaphy with no other pelvic organ involvement. Pathology showed <10% residual tumor with negative margins. Following completion of consolidation chemotherapy, imaging has shown no evidence of recurrent disease 13 months post-surgery.

{"title":"Pelvic mass in a pediatric patient: a rare case of extraosseous Ewing sarcoma.","authors":"Deepansh Dalela, Sarah Attia, Dinesh Rakheja, Shane Batie, Alexandra Carolan, Irina Stanasel","doi":"10.1016/j.urology.2025.03.038","DOIUrl":"https://doi.org/10.1016/j.urology.2025.03.038","url":null,"abstract":"<p><p>Ewing sarcoma (ES) is a common malignant bone tumor in children, but primary extraosseous Ewing sarcoma (EES) in the pelvic region is particularly rare. We report a 21-month-old male with a 10-cm complex cystic mass adherent to the bladder. Core biopsy demonstrated a small round cell neoplasm positive for CD99, NKX2-2, and EWSR1:ERG fusion. The patient had a residual mass following induction chemotherapy, and underwent surgical resection with anterior detrusorrhaphy with no other pelvic organ involvement. Pathology showed <10% residual tumor with negative margins. Following completion of consolidation chemotherapy, imaging has shown no evidence of recurrent disease 13 months post-surgery.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1